Cargando…
Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study
INTRODUCTION: Given the ageing epidemic of tuberculosis (TB), China is facing an unprecedented opportunity provided by the first clinically approved next-generation TB vaccine Vaccae, which demonstrated 54.7% efficacy for preventing reactivation from latent infection in a phase III trial. We aim to...
Autores principales: | Mao, Jun-Jie, Zang, Xiao, Yue, Wan-Lu, Zhai, Pei-Yao, Zhang, Qiong, Li, Chun-Hu, Zhuang, Xun, Liu, Min, Qin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254880/ https://www.ncbi.nlm.nih.gov/pubmed/37257938 http://dx.doi.org/10.1136/bmjgh-2023-012306 |
Ejemplares similares
-
Vaccine: From vacca, a cow
por: Turley, Patrick K.
Publicado: (2021) -
Effects of Mycobacterium vaccae vaccine in a mouse model of tuberculosis: protective action and differentially expressed genes
por: Gong, Wen-Ping, et al.
Publicado: (2020) -
Professor Vacca's Memorial on the Recto-Vesical Method of Extracting Urinary Calculi, with Cases
Publicado: (1821) -
Mycobacterium vaccae Adaptation to Disinfectants and Hand Sanitisers, and Evaluation of Cross-Tolerance with Antimicrobials
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2020) -
Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma
por: Mendes, R, et al.
Publicado: (2002)